New drug could tame lupus skin flares
NCT ID NCT04857034
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This phase 2 trial tests deucravacitinib, an anti-inflammatory pill, against a placebo in 74 adults with active discoid or subacute cutaneous lupus — skin rashes caused by lupus. The main goal is to see if the drug reduces rash severity after 16 weeks. Participants must already be on standard lupus treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
deucravacitinib (a pill that targets inflammation)
What this could lead to
If it works, this could offer a new treatment option for people with lupus-related skin rashes that don't improve with standard therapies.
What could go wrong
This is a small, early-phase trial (74 people) comparing the drug to a placebo. It may not show enough benefit, or side effects could limit its use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUPUS ERYTHEMATOSUS, DISCOID are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Local Institution
Guadalajara, Jalisco, 45030, Mexico
-
Local Institution - 0001
Kogarah, New South Wales, 2217, Australia
-
Local Institution - 0002
Camberwell, Victoria, 3124, Australia
-
Local Institution - 0003
Botany, New South Wales, 2019, Australia
-
Local Institution - 0005
Rzeszów, 35-055, Poland
-
Local Institution - 0006
Hamburg, 22391, Germany
-
Local Institution - 0007
Clayton, Victoria, 0, Australia
-
Local Institution - 0008
Lodz, Łódź Voivodeship, 94-046, Poland
-
Local Institution - 0009
Wroclaw, 50-566, Poland
-
Local Institution - 0010
Paris, 75970, France
-
Local Institution - 0013
San Miguel de Tucumán, Tucumán Province, 4000, Argentina
-
Local Institution - 0014
Erlangen, 91054, Germany
-
Local Institution - 0018
Capital Federal, Buenos Aires, 1023, Argentina
-
Local Institution - 0019
Buenos Aires, 1431, Argentina
-
Local Institution - 0021
Taichung, 404, Taiwan
-
Local Institution - 0022
Taipei, 10051, Taiwan
-
Local Institution - 0023
Taichung, 402, Taiwan
-
Local Institution - 0026
Oklahoma City, Oklahoma, 73104, United States
-
Local Institution - 0027
Créteil, 94000, France
-
Local Institution - 0028
Guadalajara, 0, Mexico
-
Local Institution - 0029
Aguascalientes, 20130, Mexico
-
Local Institution - 0031
Kaohsiung City, 833, Taiwan
-
Local Institution - 0035
Berlin, 10117, Germany
-
Local Institution - 0036
Monterrey, Nuevo León, 64718, Mexico
-
Local Institution - 0037
New York, New York, 10029, United States
-
Local Institution - 0038
Bordeaux, 33075, France
-
Local Institution - 0046
Los Angeles, California, 90045, United States
-
Local Institution - 0054
Charleston, South Carolina, 29407, United States
-
Local Institution - 0058
Zapopan, Jalisco, 45070, Mexico
-
Local Institution - 0059
St Louis, Missouri, 63108, United States
-
Local Institution - 0060
Ann Arbor, Michigan, 48109, United States
-
Local Institution - 0065
Durham, North Carolina, 27713, United States
-
Local Institution - 0067
Columbus, Ohio, 43215, United States
-
Local Institution - 0071
Mexico City, 14080, Mexico
-
Local Institution - 0072
Dresden, Saxony, 01307, Germany
-
Local Institution - 0073
Farmington, Connecticut, 06030, United States
-
Local Institution - 0076
Irvine, California, 92697, United States
-
Local Institution - 0077
Scottsdale, Arizona, 85259, United States
-
Local Institution - 0078
Melbourne, Victoria, 3004, Australia
-
Local Institution - 0082
Orlando, Florida, 32827, United States
-
Local Institution - 0087
Victoria Park, Western Australia, 6100, Australia